EC Pharmacies stock traded at EUR 14.4 per share at the end 2024 translating into a market capitalization of USD 15.9 mil. Since the end of 2019, the stock has appreciated by 0% representing an annual average growth of %.
At the end of 2024, the firm traded at price to earnings of -19.1x. Over the last five years, this multiple achieved a high of -19.1x in 2024 and a low of -19.1x in 2024 with an average of -19.1x.
Regarding cash generated defined by the sum of net profit and depreciation, the stock traded at -19.1x at the end of 2024.
At the end of 2024, the company had a net debt of EUR -0.477 mil, or 0.632x of EBITDA and -12.3% of equity. The firm generated an average return on equity of -26.9% for its shareholders in the last five years and an average dividend yield of 0%.
You can see all the company’s data at EC Pharmacies profile, or you can download a report on the company in the report section.
Helgi Library 
